BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 157569)

  • 21. [T- and B-lymphocyte reactivity in sepsis in urological patients and cadaver kidney allograft recipients].
    Dzerzhinskaia II
    Sov Med; 1978 Oct; (10):42-4. PubMed ID: 362553
    [No Abstract]   [Full Text] [Related]  

  • 22. Total and active T cell dynamics in renal allograft recipients.
    Kerman RH; Geis WP
    Surgery; 1976 Apr; 79(4):398-407. PubMed ID: 769220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytolytic pathways used by effector cells derived from recipient naive and memory T cells and natural killer cells in resistance to allogeneic hematopoietic cell transplantation.
    Zimmerman Z; Jones M; Shatry A; Komatsu M; Mammolenti M; Levy R
    Biol Blood Marrow Transplant; 2005 Dec; 11(12):957-71. PubMed ID: 16338617
    [No Abstract]   [Full Text] [Related]  

  • 24. Leukocyte migration test (LMT) in cadaver kidney transplantation.
    Sirchia G; Rosso di San Secondo V; Scalamogna M
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:191. PubMed ID: 4604695
    [No Abstract]   [Full Text] [Related]  

  • 25. Relationship of allograft function to the development of donor specific cellular nonreactivity in human cadaveric allograft recipients.
    Rashid A; Sengar DP; Couture RA; Harris JE
    Trans Am Soc Artif Intern Organs; 1976; 22():229-33. PubMed ID: 133496
    [No Abstract]   [Full Text] [Related]  

  • 26. Active T and EA-rosette-forming cells in human cadaver renal allograft recipients.
    Sengar DP; Rashid A; Harris JE
    Clin Exp Immunol; 1979 Feb; 35(2):236-41. PubMed ID: 373936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural killer-cell activity after human renal transplantation in relation to killer immunoglobulin-like receptors and human leukocyte antigen mismatch.
    Vampa ML; Norman PJ; Burnapp L; Vaughan RW; Sacks SH; Wong W
    Transplantation; 2003 Oct; 76(8):1220-8. PubMed ID: 14578757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Donor-specific cell-mediated cytotoxicity in renal allograft recipients.
    Dickmeiss E
    Acta Pathol Microbiol Scand C; 1979 Dec; 87(6):371-76. PubMed ID: 397716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporal effect of cyclosporine immunosuppression on T lymphocyte subsets, Ia-reactive cells, and donor-specific immunity in cardiac allograft recipients.
    Mazaheri R; Stiller CR; Keown P; McKenzie N; Howson W; Farrow K; McFarlane D; Sinclair NR
    Transplant Proc; 1984 Dec; 16(6):1537-9. PubMed ID: 6390861
    [No Abstract]   [Full Text] [Related]  

  • 30. Correlation of pretransplant immune parameters with the rapidity of onset of acute rejection and renal allograft survival time.
    Shabtai M; Waltzer WC; Pullis CK; Raisbeck A; Shabtai E; Malinowski K; Rapaport FT
    Transplant Proc; 1990 Aug; 22(4):1917-9. PubMed ID: 2389485
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immunological diagnosis of the kidney allograft rejection reaction].
    Drannik GN
    Urol Nefrol (Mosk); 1981; (5):64-71. PubMed ID: 6458144
    [No Abstract]   [Full Text] [Related]  

  • 32. Functional CD25(bright+) alloresponsive T cells in fully immunosuppressed renal allograft recipients.
    Baan CC; Velthuis JH; van Gurp EA; Mol WM; Klepper M; Ijzermans JN; Weimar W
    Clin Transplant; 2007; 21(1):63-71. PubMed ID: 17302593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequential changes in NK and ADCC effector cell function after organ transplantation in man.
    Hegarty JH; Ramsden CW; Dowd PS; Giles GR; Guillou PJ
    Biomed Pharmacother; 1983; 37(6):266-70. PubMed ID: 6367846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The significance of mixed lymphocyte culture and mitogen-stimulated culture for kidney transplantation (author's transl)].
    Hajek-Rosenmayr A; Wolf A
    Wien Klin Wochenschr; 1981 Jul; 93(14):457-60. PubMed ID: 6455859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tolerant T cells inhibit natural killer cells function in antigen-presenting cells in an independent fashion.
    Wang X; Yuan J; Hu J; Wu J; Gan C; He W; Luo G
    Transplant Proc; 2009 Jun; 41(5):1844-7. PubMed ID: 19545741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cytoxicity of T lymphocytes].
    Kuśnierczyk P
    Postepy Hig Med Dosw; 1977; 31(4):465-88. PubMed ID: 72383
    [No Abstract]   [Full Text] [Related]  

  • 37. Donor-specific CML hyporesponsiveness after successful renal transplantation: studies on the mechanism.
    Thomas JM; Thomas FT; Hoffman S; Johns C; Mendez-Picon G; Lee HM
    Transplant Proc; 1979 Jun; 11(2):1258-9. PubMed ID: 157568
    [No Abstract]   [Full Text] [Related]  

  • 38. Regulation of T-cell-mediated cytotoxic allograft response in human transplant recipients.
    Thomas J; Thomas F; Edwards E; Hoffman S; Lee HM
    Transplant Proc; 1981 Sep; 13(3):1594-8. PubMed ID: 6458130
    [No Abstract]   [Full Text] [Related]  

  • 39. [Antibody-dependent cell cytotoxicity and spontaneous cytotoxicity of peripheral blood lymphocytes of organ recipients and cells infiltrating the kidney allogeneic transplant].
    Drannik GN; Baran EIa; Seniuk OF; Driianskaia VE
    Fiziol Zh (1978); 1989; 35(5):68-72. PubMed ID: 2591583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-2 reconstitutes natural killer activity in transplant recipients.
    Citterio F; Cauda R; Pozzetto U; Tumbarello M; Serino F; Ortona L; Castagneto M
    Transplant Proc; 1989 Feb; 21(1 Pt 1):80-1. PubMed ID: 2784904
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.